LXEO Lexeo Therapeutics, Inc. - Common Stock
$5,31
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 12, 2026
52W-Spanne
$4–$11
19% of range
Analystenbewertung
STRONG BUY
16 analysts
Kursziel
$20
+282% upside
P/E (TTM)
-2.9
ROE
-51.9%
Nettogewinnmarge
—
LXEO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.31
Marktkapitalisierung
$388M
P/E (TTM)
-2.9
EPS (TTM)
$-1.86
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-51.9%
Verschuldungsgrad
—
52W-Spanne
$4 – $11
LXEO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2022-12-31
→
2022-12-31
EPS
$-1.86
2022-12-31
→
2025-12-31
Freier Cashflow
$-99M
2023-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
LXEO
Peer-Median
P/E (TTM)
-2.9
15.7
P/B (K/B)
1.6
4.8
Price / FCF (Kurs / FCF)
-3.9
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
LXEO
Peer-Median
ROA
-48.1%
-37.6%
ROE
-51.9%
-52.6%
ROIC
-44.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
LXEO
Peer-Median
Current Ratio (Liquiditätsgrad)
11.2
10.2
Quick Ratio
3.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
LXEO
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
LXEO
Peer-Median
LXEO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
16 Analysten
- Starker Kauf 8 50,0%
- Kauf 7 43,8%
- Halten 1 6,2%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-18
Median
$20.00
← Unter allen Zielen
$5.31
Tief
$9.00
Hoch
$30.00
Median-Ziel
$20.00
+276,4%
Mittelwert-Ziel
$20.30
+282,0%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.04%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.25 | $-0.32 | 0.07% |
| 31. Dezember 2025 | $-0.27 | $-0.32 | 0.05% |
| 30. September 2025 | $-0.33 | $-0.53 | 0.20% |
| 30. Juni 2025 | $-0.60 | $-0.69 | 0.09% |
| 31. März 2025 | $-0.99 | $-0.80 | -0.19% |
| 31. Dezember 2024 | $-0.78 | $-0.82 | 0.04% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| LXEO | $725M | -5.3 | — | — | -51.9% | — |
| CMPX | $958M | — | — | — | -45.9% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | — |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | · | · | · | $654.0K | |
| R&D Expense | $64M | $74M | $53M | $49M | |
| SG&A Expense | $45M | $32M | $15M | $12M | |
| Operating Expenses | $109M | $106M | $69M | $61M | |
| Operating Income | $-109M | $-106M | $-69M | $-61M | |
| Interest Expense | · | · | $205.0K | $91.0K | |
| Interest Income | $6M | $8M | $3M | $1M | |
| Other Non-op | $-18.0K | $-9.0K | $-13.0K | $-2.0K | |
| Pretax Income | $-100M | $-98M | $-66M | $-59M | |
| Income Tax | $0 | $0 | · | · | |
| Net Income | $-100M | $-98M | $-66M | $-59M | |
| EPS (Basic) | $-1.86 | $-3.09 | $-12.40 | $-36.36 | |
| EPS (Diluted) | $-1.86 | $-3.09 | $-12.40 | $-36.36 | |
| Shares (Basic) | 53,645,323 | 31,787,491 | 5,354,368 | 1,630,348 | |
| Shares (Diluted) | 53,645,323 | 31,787,491 | 5,354,368 | 1,630,348 | |
| EBITDA | $-109M | $-106M | $-69M | · |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $35M | $121M | $77M | |
| Short-term Investments | · | $87M | · | · | |
| Prepaid Expense | $7M | $5M | $3M | $2M | |
| Other Current Assets | · | · | $3.0K | $371.0K | |
| Current Assets | $188M | $126M | $124M | $80M | |
| PP&E (Net) | $1M | $1M | $1M | $998.0K | |
| PP&E (Gross) | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | $741.0K | $474.0K | $381.0K | $133.0K | |
| Total Assets | $269M | $147M | $140M | $97M | |
| Accounts Payable | $5M | $6M | $4M | $3M | |
| Current Liabilities | $17M | $23M | $17M | $14M | |
| Capital Leases | $5M | $6M | $8M | $9M | |
| Total Liabilities | $22M | $30M | $26M | $25M | |
| Common Stock | $7.0K | $3.0K | $3.0K | $0 | |
| Retained Earnings | $-380M | $-280M | $-182M | $-115M | |
| Treasury Stock | $17.0K | $17.0K | · | · | |
| AOCI | $188.0K | $-103.0K | · | · | |
| Stockholders' Equity | $247M | $117M | $114M | $-113M | |
| Liabilities + Equity | $269M | $147M | $140M | $97M | |
| Shares Outstanding | 73,001,350 | 33,071,261 | 26,646,378 | 1,607,185 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $268.0K | $304.0K | $271.0K | $120.0K | |
| Stock-based Comp | $12M | $12M | $3M | $2M | |
| Operating Cash Flow | $-99M | $-81M | $-59M | $-55M | |
| CapEx | $397.0K | $481.0K | $115.0K | $672.0K | |
| Investing Cash Flow | $-90M | $-94M | $-165.0K | $-901.0K | |
| Stock Issued | $270.0K | · | · | · | |
| Net Stock Activity | $270.0K | · | · | · | |
| Financing Cash Flow | $217M | $89M | $104M | $189.0K | |
| Net Change in Cash | $28M | $-86M | $44M | $-55M | |
| Taxes Paid | $551.0K | $133.0K | · | · | |
| Free Cash Flow | $-99M | $-82M | $-60M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -48.1% | -68.6% | -56.1% | · | |
| ROE | -51.9% | -76.8% | 269.5% | · | |
| ROIC | -44.3% | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 11.2 | 5.5 | 7.2 | · | |
| Quick Ratio | 3.7 | 5.3 | 7.0 | · | |
| Interest Coverage | · | · | -334.2 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-100M | $-98M | $-66M | · | |
| Market Cap | $725M | $218M | $358M | · | |
| P/E | -5.3 | -2.1 | -1.1 | · | |
| P/B | 2.9 | 1.9 | 3.1 | · | |
| P / Tangible Book | 2.9 | 1.9 | 3.1 | · | |
| P / Cash Flow | -7.4 | -2.7 | -6.0 | · | |
| P / FCF | -7.3 | -2.7 | -6.0 | · | |
| Earnings Yield | -18.7% | -47.0% | -92.4% | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| R&D Expense | $19M | $16M | $16M | $16M | $15M | $17M | $18M | $23M | $17M | $16M | $8M | $17M | $11M | $16M | $11M | |
| SG&A Expense | $9M | $7M | $7M | $6M | $16M | $17M | $9M | $8M | $7M | $8M | $7M | $3M | $3M | $3M | $4M | |
| Operating Expenses | $28M | $22M | $23M | $22M | $31M | $34M | $27M | $32M | $24M | $23M | $15M | $20M | $14M | $19M | $15M | |
| Operating Income | $-28M | $-22M | $-23M | $-22M | $-31M | $-34M | $-27M | $-32M | $-24M | $-23M | $-15M | $-20M | $-14M | $-19M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | $35.0K | $37.0K | · | $52.0K | $53.0K | $50.0K | $54.0K | |
| Interest Income | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $488.0K | $590.0K | $687.0K | $676.0K | |
| Other Non-op | $-6.0K | $-1.0K | $9.0K | $-9.0K | $-14.0K | $-4.0K | $0 | $-3.0K | $-1.0K | $-5.0K | $-7.0K | $1.0K | $-3.0K | $-4.0K | · | |
| Pretax Income | $-26M | $-20M | $-21M | $-20M | $-26M | $-33M | $-26M | $-29M | $-21M | $-22M | $-14M | $-20M | $-13M | $-19M | $-15M | |
| Net Income | $-26M | $-20M | $-21M | $-20M | $-26M | $-33M | $-26M | $-29M | $-21M | $-22M | $-14M | $-20M | $-13M | $-19M | $-15M | |
| EPS (Basic) | $-0.30 | $-0.25 | $0.06 | $-0.33 | $-0.60 | $-0.99 | $-0.79 | $-0.89 | $-0.64 | $-0.77 | $19.84 | $-12.36 | $-8.30 | $-11.58 | $-8.86 | |
| EPS (Diluted) | $-0.30 | $-0.25 | $0.06 | $-0.33 | $-0.60 | $-0.99 | $-0.79 | $-0.89 | $-0.64 | $-0.77 | $19.84 | $-12.36 | $-8.30 | $-11.58 | $-8.86 | |
| Shares (Basic) | 85,626,751 | 81,183,812 | -84,023,163 | 60,980,867 | 43,573,628 | 33,113,991 | -62,257,446 | 33,063,153 | 33,001,946 | 27,979,838 | 497,294 | 1,626,734 | 1,619,547 | 1,610,793 | 4,737 | |
| Shares (Diluted) | 85,626,751 | 81,183,812 | -84,023,163 | 60,980,867 | 43,573,628 | 33,113,991 | -62,257,446 | 33,063,153 | 33,001,946 | 27,979,838 | 497,294 | 1,626,734 | 1,619,547 | 1,610,793 | 4,737 | |
| EBITDA | $-28M | $-22M | · | $-22M | $-31M | · | · | $-32M | $-24M | $-23M | · | $-20M | · | · | · |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $72M | $63M | $41M | $35M | $29M | $35M | $157M | $175M | $195M | $121M | $35M | · | · | $77M | |
| Short-term Investments | · | · | · | · | · | $71M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $6M | $8M | $7M | $5M | $7M | $5M | $5M | $2M | $2M | $3M | $3M | $1M | · | · | $2M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | $371.0K | |
| Current Assets | $218M | $201M | $188M | $128M | $140M | $105M | $126M | $159M | $177M | $198M | $124M | $39M | · | · | $80M | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $980.0K | · | · | $998.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | · | · | $1M | |
| Accum. Depreciation | $887.0K | $814.0K | $741.0K | $668.0K | $596.0K | $534.0K | $474.0K | $610.0K | $527.0K | $450.0K | $381.0K | $316.0K | · | · | $133.0K | |
| Total Assets | $255M | $250M | $269M | $144M | $176M | $126M | $147M | $174M | $192M | $213M | $140M | $55M | · | · | $97M | |
| Accounts Payable | $4M | $3M | $5M | $5M | $20M | $12M | $6M | $8M | $6M | $4M | $4M | $3M | · | · | $3M | |
| Current Liabilities | $16M | $14M | $17M | $17M | $32M | $31M | $23M | $27M | $19M | $22M | $17M | $23M | · | · | $14M | |
| Capital Leases | $4M | $4M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | $8M | · | · | $9M | |
| Total Liabilities | $20M | $19M | $22M | $23M | $38M | $38M | $30M | $35M | $27M | $30M | $26M | $32M | · | · | $25M | |
| Common Stock | $8.0K | $7.0K | $7.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $0 | · | · | $0 | |
| Retained Earnings | $-426M | $-400M | $-380M | $-359M | $-339M | $-313M | $-280M | $-254M | $-225M | $-204M | $-182M | $-168M | · | · | $-115M | |
| Treasury Stock | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $13.0K | $13.0K | · | · | · | · | · | · | |
| AOCI | $-298.0K | $-142.0K | $188.0K | $89.0K | $-13.0K | $-54.0K | $-103.0K | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $235M | $231M | $247M | $121M | $138M | $88M | $117M | $139M | $165M | $183M | $114M | $-163M | · | · | $-113M | |
| Liabilities + Equity | $255M | $250M | $269M | $144M | $176M | $126M | $147M | $174M | $192M | $213M | $140M | $55M | · | · | $97M | |
| Shares Outstanding | 78,622,604 | 74,086,737 | 73,001,350 | 54,934,275 | 53,998,492 | 33,191,865 | 33,071,261 | 33,058,447 | 33,039,911 | 32,928,141 | 26,646,378 | 1,633,206 | · | · | 1,607,185 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $74.0K | $73.0K | $73.0K | $73.0K | $62.0K | $60.0K | $75.0K | $83.0K | $77.0K | $69.0K | $77.0K | $78.0K | $59.0K | $57.0K | $58.0K | |
| Stock-based Comp | $6M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $3M | $2M | $804.0K | $875.0K | $969.0K | $397.0K | $521.0K | |
| Operating Cash Flow | $-18M | $-21M | $-20M | $-30M | $-27M | $-22M | $-28M | $-18M | $-20M | $-15M | $-14M | $-14M | $-13M | $-18M | $-17M | |
| CapEx | $7.0K | $35.0K | $0 | $289.0K | · | · | $0 | $83.0K | $213.0K | $185.0K | $73.0K | $3.0K | · | · | $25.0K | |
| Investing Cash Flow | $14M | $27M | $-102M | $35M | $-39M | $16M | $-94M | $-83.0K | $-218.0K | $-193.0K | $-73.0K | $-53.0K | · | · | $-107.0K | |
| Stock Issued | $25M | $143.0K | $-1.0K | $101.0K | $0 | $170.0K | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $143.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $144M | $52.0K | $73M | $11.0K | $-97.0K | $-72.0K | $291.0K | $89M | $100M | $4M | $-94.0K | $-98.0K | $-81.0K | |
| Net Change in Cash | $21M | $9M | $22M | $6M | $7M | $-6M | $-122M | $-18M | $-20M | $74M | $86M | $-10M | $-13M | $-18M | $-17M | |
| Free Cash Flow | · | $-21M | · | · | · | · | · | · | · | $-15M | · | · | · | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.0% | -10.7% | · | -12.8% | -14.2% | · | · | -25.8% | -22.1% | -20.3% | · | -73.5% | · | · | · | |
| ROE | -13.9% | -12.6% | · | -15.6% | -17.2% | · | · | 251.2% | -25.8% | -23.7% | · | 24.7% | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.9 | 14.2 | · | 7.4 | 4.4 | · | · | 5.9 | 9.4 | 9.2 | · | 1.7 | · | · | · | |
| Quick Ratio | 5.9 | 5.1 | · | 2.4 | 1.1 | · | · | 5.9 | 9.3 | 9.0 | · | 1.5 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -672.9 | -629.5 | · | -389.9 | · | · | · |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-92M | $-99M | · | $-109M | $-109M | $-105M | · | $-93M | $-76M | $-74M | · | $-69M | · | · | · | |
| Market Cap | $366M | $425M | · | $365M | $217M | · | · | $299M | $530M | $516M | · | · | · | · | · | |
| P/E | -3.1 | -2.6 | · | -2.4 | -1.3 | -1.1 | · | -0.6 | -0.7 | -0.5 | · | · | · | · | · | |
| P/B | 1.6 | 1.8 | · | 3.0 | 1.6 | · | · | 2.1 | 3.2 | 2.8 | · | · | · | · | · | |
| P / Tangible Book | 1.6 | 1.8 | · | 3.0 | 1.6 | 1.3 | · | 2.1 | 3.2 | 2.8 | · | · | · | · | · | |
| P / Cash Flow | · | -20.1 | · | · | · | · | · | · | · | -34.7 | · | · | · | · | · | |
| P / FCF | · | -20.1 | · | · | · | · | · | · | · | -34.3 | · | · | · | · | · | |
| Earnings Yield | -31.8% | -37.8% | · | -42.3% | -77.6% | -94.8% | · | -162.2% | -137.6% | -210.5% | · | · | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Umsatz | — | — | — | $654.0K |
| Nettoergebnis | $-100M | $-98M | $-66M | $-59M |
| Verwässerte EPS | $-1.86 | $-3.09 | $-12.40 | $-36.36 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Liquiditätsgrad | 11.2 | 5.5 | 7.2 | — |
| Quick Ratio | 3.7 | 5.3 | 7.0 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Freier Cashflow | $-99M | $-82M | $-60M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 151 Einreicher · $350.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 35 (+12 vs. Vorquartal) | 19 (-5 vs. Vorquartal) | 50 (-2 vs. Vorquartal) | 40 (+3 vs. Vorquartal) | +8.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $29.718.451 | 6.384.200 | 8,47% | Aktien |
| Affinity Asset Advisors, LLC | $27.034.429 | 5.807.611 | 7,71% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $23.275.000 | 5.000.000 | 6,64% | Aktien |
| Frazier Life Sciences Management, L.P. | $22.459.095 | 4.824.725 | 6,40% | Aktien |
| STATE STREET CORP | $20.271.394 | 4.354.757 | 5,78% | Aktien |
| Vestal Point Capital, LP | $20.109.600 | 4.320.000 | 5,73% | Aktien |
| Paradigm Biocapital Advisors LP | $19.436.403 | 4.175.382 | 5,54% | Aktien |
| ORBIMED ADVISORS LLC | $18.377.242 | 3.947.850 | 5,24% | Aktien |
| CITADEL ADVISORS LLC | $17.167.486 | 3.687.967 | 4,89% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $14.551.032 | 3.125.893 | 4,15% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $13.190.510 | 2.833.622 | 3,76% | Aktien |
| Woodline Partners LP | $11.639.976 | 2.500.532 | 3,32% | Aktien |
| Balyasny Asset Management L.P. | $11.231.314 | 2.412.742 | 3,20% | Aktien |
| 683 Capital Management, LLC | $8.728.124 | 1.875.000 | 2,49% | Aktien |
| GOLDMAN SACHS GROUP INC | $8.094.123 | 1.738.802 | 2,31% | Aktien |
| ADAR1 Capital Management, LLC | $7.289.497 | 1.565.950 | 2,08% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $7.030.374 | 1.509.898 | 2,00% | Aktien |
| Avoro Capital Advisors LLC | $6.932.175 | 1.489.189 | 1,98% | Aktien |
| Qube Research & Technologies Ltd | $6.406.313 | 1.376.222 | 1,83% | Aktien |
| Nantahala Capital Management, LLC | $6.051.500 | 1.300.000 | 1,73% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $5.599.365 | 1.202.871 | 1,60% | Aktien |
| Spruce Street Capital LP | $4.322.600 | 928.593 | 1,23% | Aktien |
| Blackstone Inc. | $4.217.109 | 904.959 | 1,20% | Aktien |
| Aberdeen Group plc | $3.142.553 | 675.092 | 0,90% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.857.360 | 613.826 | 0,81% | Aktien |
| Ikarian Capital, LLC | $2.388.066 | 513.011 | 0,68% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.076.083 | 445.990 | 0,59% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.004.890 | 430.696 | 0,57% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.807.993 | 388.398 | 0,52% | Aktien |
| DAFNA Capital Management LLC | $1.755.210 | 377.059 | 0,50% | Aktien |
| UBS Group AG | $1.646.785 | 353.767 | 0,47% | Aktien |
| Trexquant Investment LP | $1.465.818 | 314.891 | 0,42% | Aktien |
| Squarepoint Ops LLC | $1.372.173 | 294.774 | 0,39% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.165.449 | 250.365 | 0,33% | Aktien |
| TWO SIGMA ADVISERS, LP | $807.309 | 81.300 | 0,23% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $803.495 | 172.609 | 0,23% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $749.744 | 161.062 | 0,21% | Aktien |
| Privium Fund Management B.V. | $722.300 | 155.000 | 0,21% | Aktien |
| XTX Topco Ltd | $677.563 | 145.556 | 0,19% | Aktien |
| FMR LLC | $657.035 | 141.146 | 0,19% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $634.835 | 136.377 | 0,18% | Aktien |
| Burkehill Global Management, LP | $581.875 | 125.000 | 0,17% | Aktien |
| MORGAN STANLEY | $546.800 | 117.465 | 0,16% | Aktien |
| Palumbo Wealth Management LLC | $534.129 | 114.743 | 0,15% | Aktien |
| Fisher Asset Management, LLC | $532.168 | 114.322 | 0,15% | Aktien |
| EntryPoint Capital, LLC | $482.481 | 103.648 | 0,14% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $446.916 | 77.860 | 0,13% | Aktien |
| CITIGROUP INC | $417.330 | 89.652 | 0,12% | Aktien |
| VANGUARD GROUP INC | $375.265 | 37.791 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $371.505 | 79.809 | 0,11% | Aktien |
| Virtus Investment Advisers, LLC | $348.538 | 74.874 | 0,10% | Aktien |
| Walleye Capital LLC | $343.856 | 73.868 | 0,10% | Aktien |
| Rafferty Asset Management, LLC | $314.375 | 67.535 | 0,09% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $307.677 | 66.096 | 0,09% | Aktien |
| Bank of New York Mellon Corp | $303.059 | 65.104 | 0,09% | Aktien |
| WELLS FARGO & COMPANY/MN | $276.344 | 59.365 | 0,08% | Aktien |
| JANE STREET GROUP, LLC | $241.129 | 51.800 | 0,07% | Verkaufsoption |
| Mitsubishi UFJ Asset Management Co., Ltd. | $232.694 | 49.988 | 0,07% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $224.948 | 48.324 | 0,06% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $224.259 | 48.176 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $184.096 | 39.548 | 0,05% | Aktien |
| PROFUND ADVISORS LLC | $159.746 | 34.317 | 0,05% | Aktien |
| Dynamic Technology Lab Private Ltd | $152.000 | 32.651 | 0,04% | Aktien |
| Verdad Advisers, LP | $142.401 | 30.591 | 0,04% | Aktien |
| ExodusPoint Capital Management, LP | $129.781 | 27.880 | 0,04% | Aktien |
| BlackRock, Inc. | $124.284 | 26.699 | 0,04% | Aktien |
| Invesco Ltd. | $122.515 | 26.319 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $118.865 | 25.535 | 0,03% | Aktien |
| AlphaQuest LLC | $116.439 | 11.726 | 0,03% | Aktien |
| Quantinno Capital Management LP | $113.084 | 24.293 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $108.857 | 23.385 | 0,03% | Aktien |
| CWM, LLC | $105.140 | 18.317 | 0,03% | Aktien |
| PRELUDE CAPITAL MANAGEMENT, LLC | $104.738 | 22.500 | 0,03% | Aktien |
| Soltis Investment Advisors LLC | $93.174 | 20.016 | 0,03% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $92.574 | 19.887 | 0,03% | Aktien |
| D. E. Shaw & Co., Inc. | $92.476 | 19.866 | 0,03% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $92.192 | 19.805 | 0,03% | Aktien |
| Vanguard Personalized Indexing Management, LLC | $90.614 | 19.466 | 0,03% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $87.770 | 18.855 | 0,03% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $86.118 | 18.500 | 0,02% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $82.938 | 17.817 | 0,02% | Aktien |
| CAXTON CORP | $78.959 | 16.962 | 0,02% | Aktien |
| Jain Global LLC | $77.203 | 16.585 | 0,02% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76.424 | 16.400 | 0,02% | Kaufoption |
| JANUS HENDERSON GROUP PLC | $74.001 | 12.926 | 0,02% | Aktien |
| Spark Investment Management LLC | $69.825 | 15.000 | 0,02% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $66.241 | 14.230 | 0,02% | Aktien |
| Cerity Partners LLC | $64.756 | 13.911 | 0,02% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $61.431 | 12.745 | 0,02% | Aktien |
| DEUTSCHE BANK AG\ | $61.176 | 13.128 | 0,02% | Aktien |
| BARCLAYS PLC | $59.236 | 12.725 | 0,02% | Aktien |
| China Universal Asset Management Co., Ltd. | $58.174 | 12.497 | 0,02% | Aktien |
| ProShare Advisors LLC | $55.175 | 11.853 | 0,02% | Aktien |
| PRUDENTIAL FINANCIAL INC | $53.928 | 11.585 | 0,02% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $51.780 | 11.123 | 0,01% | Aktien |
| NORTHERN TRUST CORP | $51.773 | 11.122 | 0,01% | Aktien |
| Tyche Wealth Partners LLC | $46.550 | 10.000 | 0,01% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $37.734 | 7.845 | 0,01% | Aktien |
| Legal & General Group Plc | $32.036 | 6.882 | 0,01% | Aktien |
| Nuveen Asset Management, LLC | $31.683 | 4.815 | 0,01% | Aktien |
Unternehmensinsider 15 Insider · 7 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Richard Nolan Townsend | Chief Executive Officer | 1. Juli 2026 S | 377.817 | 0 | 1 | $-116.243 |
| Louis Edward Tamayo | Chief Financial Officer | 1. Juli 2026 S | 97.024 | 0 | 1 | $-20.838 |
| Jose Manuel Otero | Chief Operating Officer | 1. Juli 2026 S | 137.482 | 0 | 1 | $-20.904 |
| Narinder Pal Bhalla | Chief Medical Officer | 1. Juli 2026 S | 82.194 | 0 | 1 | $-98.593 |
| Eric Adler | Chief Medical Officer | 2. Februar 2024 A | 26.875 | 0 | 0 | $0 |
| Jenny Robertson | Chief Legal and Admin Officer | 5. Januar 2024 A | 23.750 | 0 | 0 | $0 |
| Paul Mccormac | Chief Technical Officer | 7. November 2023 C | 17.349 | 0 | 0 | $0 |
| Brenda Cooperstone | Direktor | 25. Juni 2026 A | — | 0 | 0 | $0 |
| Tolga Tanguler | Direktor | 25. Juni 2026 A | — | 0 | 0 | $0 |
| Timothy Van Hauwermeiren | Direktor | 25. Juni 2026 A | — | 0 | 0 | $0 |
| Mette Kirstine Agger | Direktor | 25. Juni 2026 A | — | 0 | 0 | $0 |
| Steven Altschuler | Direktor | 25. Juni 2026 A | — | 0 | 0 | $0 |
| Reinaldo M Diaz | Direktor | 25. Juni 2026 A | — | 0 | 0 | $0 |
| CHOLMONDELEY PAULA H | Direktor | 25. Juni 2026 A | — | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | 10%-Eigentümer | 7. November 2023 C | 1.835.959 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 31 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,43% | 28.249 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,12% | 108.595 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 0,02% | 2.697 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 27.676 NS | 30. April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 245.482 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 3.114 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 2.434 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 2.460 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 18.677 NS | 31. Mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1.683 NS | 30. April 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 62 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.041 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 110.788 NS | 30. April 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 5.030 NS | 30. April 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.083 NS | 30. April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 18.508 NS | 30. April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 2.700 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30. Juli 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| ITOT · iShares Trust | — | — | 4. August 2026 | Täglich |
| IWV · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWN · iShares Trust | — | — | 17. August 2026 | Täglich |
| IWM · iShares Trust | — | — | 18. August 2026 | Täglich |
| IBB · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWC · iShares Trust | — | — | 18. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13. Juli 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20. Juli 2026 | Täglich |